Natural Killer Lysis Receptor (NKLR)/NKLR-Ligand Matching as a Novel Approach for Enhancing Anti-Tumor Activity of Allogeneic NK Cells
Gal Markel, Rachel Seidman, Michal J. Besser et al. · 2009
Read Natural Killer Lysis Receptor (NKLR)/NKLR-Ligand Matching as a Novel Approach for Enhancing Anti-Tumor Activity of Allogeneic NK Cells by Gal Markel, Rachel Seidman, Michal J. Besser et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0005597.txt.
Description
Gal Markel and co-authors tested a way to boost natural killer cells against tumours in a 2009 PLOS ONE report. Natural killer cells are immune cells that can kill cancer cells without prior training. They are used in cell therapies, above all around stem cell transplants.
The team matched a receptor on the killer cells with its partner on target cells to pick stronger pairings. Choosing donors whose cells match in the right way could make the therapy hit tumours harder. That would be welcome in cancers that resist other treatments. Stronger killer cells could also help patients whose own immune systems are weakened by transplant drugs.
Catalog record
| CREATOR | Gal Markel, Rachel Seidman, Michal J. Besser et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0005597